Biograph
PrivateLast Round
Early Funding
Feb 27, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biograph is a healthcare company that provides advanced diagnostic testing and preventive health services focused on longevity and early disease detection.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical Imaging, Medical AI, D2C Brands
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biograph Comparables
Compare Biograph with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Human Longevity | 87% | |
| Prenuvo | 86% | |
| Fountain Life | 86% |
Biograph Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 27, 2025 |
Biograph Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Early Funding |
| WndrCo | Early Funding |
| Vy Capital | Early Funding |
| Alpha Wave Global | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
New clinic opening in San Mateo, CA.
- Sep 30, 2025
Partnered with Caristo Diagnostics to study novel AI-based preventive cardiac marker.
Biograph Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biograph's valuation, stock price, and market status.
Is Biograph a public or private company?
Biograph is a private company.
What is the current stock price of Biograph?
Biograph is a private company with no public stock price. No recent secondary market data is available.
How much is Biograph worth (valuation)?
Valuation information for Biograph is not publicly available.
Can I buy Biograph stock?
Biograph shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biograph's last funding round?
Biograph's most recent funding round was Seed on February 28, 2025.
Who are the main investors in Biograph?
Key investors in Biograph include Human Capital, WndrCo, Vy Capital, Alpha Wave Global.
Will Biograph IPO soon?
No public IPO plans have been announced for Biograph.
How can I track Biograph secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biograph's secondary market activity and sign up for updates.